Core Viewpoint - Bohai Chemical (600800.SH) plans to publicly transfer its property located at 325 Jiefang South Road, Hexi District, Tianjin, with a minimum listing price of RMB 137 million, with the final transaction amount to be determined by the actual sale price [1] Summary by Relevant Categories Company Actions - The company is initiating a public listing for the transfer of its property, indicating a strategic move to capitalize on its real estate assets [1] - The pricing strategy is based on a comprehensive assessment of the industrial property’s valuation, future commercial value, potential for building renovation appreciation, and stable long-term rental income [1] Financial Aspects - The minimum listing price for the property is set at RMB 137 million, reflecting a premium pricing approach within a reasonable range [1] - The actual transfer price will be determined based on the final listing transaction price, suggesting potential for variability in the final financial outcome [1]

Core Viewpoint - Bohai Chemical (600800.SH) plans to publicly transfer its idle asset located at 325 Jiefang South Road, Hexi District, Tianjin, for no less than 137 million yuan to enhance operational efficiency and align with its strategic development needs [1] Group 1: Asset Transfer Details - The asset's book value as of March 31, 2025, is 27.2345 million yuan, while its assessed value is 66.4544 million yuan, indicating an appreciation rate of 144.01% [1] - The anticipated profit from this asset disposal is projected to be 90 million yuan if the asset is sold at the listed price [1] Group 2: Strategic Implications - The transaction aims to focus on the company's core business development, reduce operational costs, and improve asset utilization efficiency [1]

Core Viewpoint - Bohai Chemical (600800.SH) plans to publicly transfer its property located at 325 Jiefang South Road, Hexi District, Tianjin, for no less than 137 million yuan to enhance operational efficiency and focus on core business development [1] Group 1: Asset Transfer Details - The property has a book value of 27.2345 million yuan and an assessed value of 66.4544 million yuan, indicating an appreciation rate of 144.01% [1] - The anticipated profit from this asset disposal is projected to be 90 million yuan if the property is sold at the listed price [1] Group 2: Strategic Intent - The transaction aligns with the company's strategic development needs by revitalizing idle assets and reducing operational costs [1] - The company aims to improve asset utilization efficiency through this transfer [1]

证券代码：600800 证券简称：渤海化学 编号：临 2025-042 天津渤海化学股份有限公司 一、会议主题 天津渤海化学股份有限公司（以下简称"公司"）为进一步加强 与投资者的沟通交流，公司定于 2025 年 9 月 11 日（周四）下午 15:00-17:00 期间参加由天津证监局主办、天津上市公司协会与深圳 市全景网络有限公司共同协办的"2025 年投资者网上集体接待日暨 半年报业绩说明会"活动。本次活动将采用网络远程的方式举行，投 资者可登录"全景路演"网站（http://rs.p5w.net）；或关注微信公 众号（名称：全景财经）；或下载全景路演 APP，参与本次互动交流。 二、召开时间和方式 会议召开时间：2025 年 9 月 11 日（周四）下午 15:00-17:00 会议召开地点：全景路演（http://rs.p5w.net） 会议召开方式：网络互动交流 三、出席会议人员 关于参加"天津辖区上市公司 2025 年投资者网上集体接待 日暨半年报业绩说明会"的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 ...

Core Viewpoint - Bohai Chemical's stock price has decreased by 8.97% over the past week, with a current market capitalization of 4.16 yuan and a total market value of 4.618 billion yuan [1] Group 1: Stockholder Changes - As of June 30, 2025, the number of shareholders for Bohai Chemical is 51,500, a decrease of 5,464 shareholders or 9.59% compared to March 31, 2025 [2] Group 2: Performance Disclosure Highlights - Bohai Chemical's mid-year report for 2025 shows a main revenue of 1.961 billion yuan, a year-on-year decrease of 21.73% - The net profit attributable to shareholders is -359 million yuan, down 13.68% year-on-year - The second quarter alone reported a main revenue of 1.122 billion yuan, a decline of 6.46% year-on-year, with a net profit of -190 million yuan, down 37.38% year-on-year - The company's debt ratio stands at 65.01%, with a gross profit margin of -9.24% and financial expenses of 25.37 million yuan [3][6] Group 3: Company Announcements Summary - Bohai Chemical will not distribute profits or increase capital reserves for the first half of 2025 - The board has approved the half-year report and related financial assessments - Tianjin Bohai Group Financial Co., Ltd. reported total assets of 7.156 billion yuan and total liabilities of 5.284 billion yuan as of June 30, 2025 - The company raised a total of approximately 706 million yuan through a non-public offering, with a remaining balance of about 257 million yuan for new material projects due to previous project overcapacity [4][6]

Core Insights - Bohai Chemical (600800) reported a significant decline in financial performance for the first half of 2025, with total revenue of 1.961 billion yuan, down 21.73% year-on-year, and a net loss attributable to shareholders of 359 million yuan, a decrease of 13.68% compared to the previous year [1] Financial Performance Summary - Total revenue for the second quarter was 1.122 billion yuan, reflecting a year-on-year decrease of 6.46% [1] - The company's gross margin was -9.24%, down 12.23% year-on-year, while the net margin fell to -18.29%, a decline of 45.25% [1] - Total expenses (selling, administrative, and financial) amounted to 89.03 million yuan, representing 4.54% of revenue, an increase of 43.46% year-on-year [1] - Earnings per share decreased to -0.32 yuan, down 14.29% year-on-year, and operating cash flow per share was -0.37 yuan, a drastic decline of 447.27% [1] Balance Sheet Analysis - Cash and cash equivalents decreased by 60.64% to 509 million yuan due to increased funding needs for production recovery [3] - Short-term borrowings increased by 41.93% to 1.858 billion yuan, indicating rising debt pressure [11] - The current ratio stood at 0.73, highlighting liquidity concerns [1] Operational Insights - Accounts receivable decreased by 11.23% to 59.13 million yuan, while inventory surged by 141.07% due to increased raw material and finished goods requirements [4][7] - The company experienced a 21.73% decline in operating income, attributed to decreased production and sales [19] - Research and development expenses fell by 17.71%, indicating reduced investment in innovation [23] Cash Flow and Investment Activities - Net cash flow from operating activities plummeted by 447.27%, primarily due to reduced income from sales [24] - Cash flow from investment activities decreased significantly by 1168.73%, driven by increased investment in fundraising projects [25] - Cash flow from financing activities rose by 35.8%, reflecting an increase in borrowings [26] Historical Performance Context - The company's historical financial performance has been weak, with a median Return on Invested Capital (ROIC) of 2.56% over the past decade, and 11 years of losses since its listing [27] - The business model relies heavily on R&D and capital expenditures, necessitating careful scrutiny of the viability of these investments [27]

Group 1 - Bohai Chemical announced the convening of its 17th meeting of the 10th board of directors on August 26, 2025, to review the 2025 semi-annual report and summary [1] - For the year 2024, Bohai Chemical's revenue composition is as follows: Chemicals account for 98.5%, magnetic cards for 0.92%, printing industry for 0.34%, machinery products for 0.23%, and other businesses for 0.01% [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices for industry-listed companies [1]

Core Viewpoint - Tianjin Bohai Chemical Co., Ltd. conducted a risk assessment report on Tianjin Bohai Group Financial Co., Ltd., confirming its compliance with regulatory requirements and evaluating its operational and risk management capabilities [1][16]. Group 1: Company Overview - Tianjin Bohai Group Financial Co., Ltd. was established on November 4, 1992, as a non-bank financial institution, being the first enterprise group financial company in Tianjin [1]. - The registered capital is 1 billion RMB, with a planned increase to 1.5 billion RMB following approval from the Tianjin Financial Regulatory Bureau [1]. - The company has various membership qualifications, including participation in the national interbank lending center and other financial associations [1]. Group 2: Business Scope - The financial company’s business includes accepting deposits from member units, providing loans, bill discounting, bill acceptance, fund settlement, and various financial advisory services [1]. Group 3: Internal Control and Risk Management - The financial company has established a comprehensive risk management system covering market, credit, operational, liquidity, compliance, and reputational risks [2][3]. - Daily risk monitoring focuses on key indicators such as capital adequacy ratio, liquidity ratio, and non-performing asset ratio [3]. - The governance structure includes a board of directors, supervisory board, and senior management, ensuring effective oversight and compliance [3]. Group 4: Financial Performance - As of June 30, 2025, the total assets of the financial company reached 7.156 billion RMB, a 24.55% increase from the previous year [14]. - The total liabilities amounted to 5.284 billion RMB, reflecting a 25.10% growth year-on-year [14]. - The company achieved an operating income of 84.2315 million RMB in the first half of 2025, meeting 49.32% of its annual budget target [14]. Group 5: Regulatory Compliance - The financial company adheres to the regulations set forth by the China Banking and Insurance Regulatory Commission, with all supervisory indicators within acceptable limits [15][16]. - The company has not identified any significant deficiencies in its risk management framework since its establishment [16].

Core Viewpoint - The report details the fundraising activities and the usage of raised funds by Tianjin Bohai Chemical Co., Ltd. for the period ending June 30, 2025, highlighting the management, allocation, and changes in investment projects. Fundraising Overview - The company raised a total of RMB 706.02 million through a non-public offering of 183,381,314 shares at RMB 3.85 per share, with the funds verified by an independent auditor [1][2]. - The funds are managed under specific regulations and stored in dedicated accounts to ensure proper usage and efficiency [1][2]. Fund Management - The company has established a fundraising management method to ensure that the funds are used efficiently and in compliance with relevant regulations [1][2]. - A four-party supervision agreement was signed with independent financial advisors and banks to oversee the management of the raised funds [1][2]. Fund Usage - As of June 30, 2025, the total amount of funds used was RMB 281.55 million, with RMB 200 million temporarily allocated to supplement working capital and RMB 281.55 million invested in projects [1][2][3]. - The remaining balance of the raised funds was RMB 256.78 million after accounting for the temporary working capital allocation [1][2][3]. Project Changes - The company changed the investment focus from the "Propane Dehydrogenation Unit Technology Transformation Project" to the "Acrylic Ester and Superabsorbent Resin New Material Project" due to market conditions affecting the original project [2][6]. - The new project is located in the Tianjin Port Free Trade Zone and is currently being implemented as planned [2][6]. Idle Fund Management - The company has not engaged in cash management activities for idle funds during the reporting period [3]. - A resolution was passed to use up to RMB 350 million of idle funds for cash management, with a rolling usage period of up to 12 months [2][3]. Investment Project Status - The company has not transferred or replaced any investment projects with the raised funds, and the projects are being executed according to the planned schedule [1][2][3]. - The company has confirmed that the actual usage of funds aligns with the disclosures in periodic reports, with no significant discrepancies noted [1][2].

Core Viewpoint - The report provides an audit of Tianjin Bohai Chemical Co., Ltd.'s fundraising activities and the actual use of raised funds for the first half of 2025, confirming compliance with regulations and accurate reporting of fund usage [1][2]. Fundraising Overview - The company raised a total of RMB 706,018,058.90 through a non-public offering of 183,381,314 shares at RMB 3.85 per share, with net proceeds amounting to RMB 69,895.79 million after deducting issuance costs [2][3]. - The funds are managed under a specific management plan to ensure proper usage and efficiency, with dedicated accounts for storage [2][3]. Fund Storage and Usage - As of June 30, 2025, the total balance of the raised funds was RMB 25,677.51 million after accounting for various expenditures, including RMB 20,000 million temporarily used for working capital and RMB 28,154.60 million invested in projects [2][3]. - The company has established a four-party supervision agreement for the management of the raised funds, ensuring compliance with regulatory requirements [2][3]. Project Investment and Changes - The company has changed the investment focus from the "Propane Dehydrogenation Unit Technical Transformation Project" to the "Acrylic Ester and Super Absorbent Resin New Material Project" due to market conditions affecting the feasibility of the original project [2][3][5]. - The new project is currently being implemented as planned, with no significant changes in feasibility reported [5][6]. Idle Fund Management - The company has not engaged in cash management activities for idle funds during the reporting period, and no permanent use of excess funds for working capital or loan repayment has occurred [4][6]. - A temporary use of up to RMB 20,000 million of idle funds for working capital was approved, with a commitment to return the funds to the dedicated account as needed [4][6].